Clarithromycine Mylan EPD Forte 500 mg compr. pellic. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

clarithromycine mylan epd forte 500 mg compr. pellic.

viatris bv-srl - clarithromycine 500 mg - comprimé pelliculé - 500 mg - clarithromycine 500 mg - clarithromycin

Clarithromycine Mylan EPD Uno 500 mg compr. lib. modif. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

clarithromycine mylan epd uno 500 mg compr. lib. modif.

viatris bv-srl - clarithromycine 500 mg - comprimé à libération modifiée - 500 mg - clarithromycine 500 mg - clarithromycin

Clarithromycine Sandoz 250 mg compr. pellic. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

clarithromycine sandoz 250 mg compr. pellic.

sandoz sa-nv - clarithromycine 250 mg - comprimé pelliculé - 250 mg - clarithromycine 250 mg - clarithromycin

Clarithromycine Sandoz 500 mg compr. pellic. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

clarithromycine sandoz 500 mg compr. pellic.

sandoz sa-nv - clarithromycine 500 mg - comprimé pelliculé - 500 mg - clarithromycine 500 mg - clarithromycin

Clarithromycine Teva 500 mg compr. pellic. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

clarithromycine teva 500 mg compr. pellic.

teva pharma belgium sa-nv - clarithromycine 500 mg - comprimé pelliculé - 500 mg - clarithromycine 500 mg - clarithromycin

Clarithromycine Teva 250 mg compr. pellic. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

clarithromycine teva 250 mg compr. pellic.

teva pharma belgium sa-nv - clarithromycine 250 mg - comprimé pelliculé - 250 mg - clarithromycine 250 mg - clarithromycin

CLARITHROMYCIN SANDOZ clarithromycin 500 mg film-coated tablets blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clarithromycin sandoz clarithromycin 500 mg film-coated tablets blister pack

sandoz pty ltd - clarithromycin, quantity: 500 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; croscarmellose sodium; macrogol 4000; hypromellose; titanium dioxide; microcrystalline cellulose; powdered cellulose - clarithromycin sandoz clarithromycin is indicated for use in adults and children older than 12 years for the treatment of mild to moderately severe infections caused by susceptible strains of the designated micro-organisms in the conditions listed below: acute streptococcal pharyngitis; community acquired pneumonia due to chlamydia pneumoniae, mycoplasma pneumoniae, legionella pneumophilia and streptococcus pneumoniae;uncomplicated skin and skin structure infections due to staphylococcus aureus or streptococcus pyogenes;disseminated or localised mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare and skin and skin structure infections due to mycobacterium chelonae. clarithromycin should be used in combination with other anti mycobacterial agents.prevention of disseminated mycobacterium avium complex infection in hiv infected adults with cd4 lymphocyte counts <75 cells/mm 3 (see precautions). disseminated infection due to mycobacterium avium complex should be excluded by a negat

CLARITHROMYCIN SANDOZ clarithromycin 250 mg film-coated tablets blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clarithromycin sandoz clarithromycin 250 mg film-coated tablets blister pack

sandoz pty ltd - clarithromycin, quantity: 250 mg - tablet, film coated - excipient ingredients: titanium dioxide; powdered cellulose; magnesium stearate; hypromellose; macrogol 4000; croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; lactose monohydrate - clarithromycin sandoz clarithromycin is indicated for use in adults and children older than 12 years for the treatment of mild to moderately severe infections caused by susceptible strains of the designated micro-organisms in the conditions listed below: acute streptococcal pharyngitis; community acquired pneumonia due to chlamydia pneumoniae, mycoplasma pneumoniae, legionella pneumophilia and streptococcus pneumoniae;uncomplicated skin and skin structure infections due to staphylococcus aureus or streptococcus pyogenes;disseminated or localised mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare and skin and skin structure infections due to mycobacterium chelonae. clarithromycin should be used in combination with other anti mycobacterial agents.prevention of disseminated mycobacterium avium complex infection in hiv infected adults with cd4 lymphocyte counts <75 cells/mm 3 (see precautions). disseminated infection due to mycobacterium avium complex should be excluded by a negat

CLARITHROMYCIN/MYLAN 500MG/TAB ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

clarithromycin/mylan 500mg/tab επικαλυμμενο με λεπτο υμενιο δισκιο

mylan s.a.s., saint priest, france (0000008105) 117 allee des pares, 69800, saint priest - clarithromycin - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 500mg/tab - ineof00310 clarithromycin 500.000000 mg - clarithromycin

CLARITHROMYCIN/MYLAN 250MG/TAB ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

clarithromycin/mylan 250mg/tab επικαλυμμενο με λεπτο υμενιο δισκιο

mylan s.a.s., saint priest, france (0000008105) 117 allee des pares, 69800, saint priest - clarithromycin - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 250mg/tab - ineof00310 clarithromycin 250.000000 mg - clarithromycin